Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Eledon Pharmaceuticals, Inc. (ELDN) had Weighted-Average Shares Outstanding (Basic) of 77.16M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-11.22M |
|
-- |
|
-- |
|
$24.73M |
|
$-24.73M |
|
$13.52M |
|
$-11.22M |
|
$-11.22M |
|
$-11.22M |
|
$-11.22M |
|
$-11.22M |
|
$-11.22M |
|
$-24.73M |
|
$-24.73M |
|
|
Weighted-Average Shares Outstanding (Basic) |
77.16M |
77.16M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$111.40M |
|
-- |
|
$33.51M |
|
$144.91M |
|
$13.72M |
|
-- |
|
$25.16M |
|
$38.88M |
|
$50.33M |
|
$106.03M |
|
$106.03M |
|
59.88M |
|
| Cash Flow Statement Financials | |
$-33.77M |
|
$18.85M |
|
$0.12M |
|
$20.55M |
|
$5.74M |
|
$-14.81M |
|
$5.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.28% |
|
-10.58% |
|
-7.74% |
|
-10.58% |
|
$1.77 |
|
$-0.44 |
|
$-0.44 |
|